Press Releases

Webcast
42nd Annual Canaccord Genuity Growth Conference
Thursday, August 11, 2022 12:00 PM EDT

Keyword Search

Date Title
August 4, 2022
iRhythm Technologies Announces Second Quarter 2022 Financial Results
SAN FRANCISCO , Aug. 04, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, today reported financial results for the three months ended June 30, 2022 .
July 28, 2022
iRhythm Technologies to Present at the Canaccord Genuity 42nd Annual Growth Conference
SAN FRANCISCO , July 28, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, today announced the company will be participating in the upcoming Canaccord Genuity 42nd Annual Growth Stock
July 25, 2022
iRhythm Technologies Announces the Addition of Two Executive Leaders to Advance Strategic Growth and Operational Excellence
SAN FRANCISCO , July 25, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, today announced the appointment of two seasoned executives to its leadership team.
July 22, 2022
iRhythm Gains FDA Clearance for its Clinically Integrated ZEUS System
Developed in partnership with Verily, the Zio® Watch and the ZEUS System combine to create a clinical grade watch to detect and characterize AFib and integrate with clinician’s workflow SAN FRANCISCO , July 22, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc.
July 18, 2022
iRhythm Technologies Announces Chief Commercial Officer Transition and Schedules Second Quarter Earnings Release and Conference Call for August 4, 2022
SAN FRANCISCO , July 18, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, today announced that Dave Vort , the Company’s Chief Commercial Officer, has resigned effective July 25, 2022 .
July 8, 2022
iRhythm® Technologies Comments on the Proposed Medicare Physician Fee Schedule Released by the Centers for Medicare and Medicaid Services for Calendar Year 2023
SAN FRANCISCO , July 08, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, today provided comment on the recently released Centers for Medicare and Medicaid Services (“CMS”) Medicare
May 25, 2022
iRhythm Technologies to Present at the 42nd Annual William Blair Growth Stock Conference
SAN FRANCISCO , May 25, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today announced the company will be participating in the upcoming 42nd Annual William Blair Growth Stock Conference
May 5, 2022
iRhythm Technologies Announces First Quarter 2022 Financial Results
SAN FRANCISCO , May 05, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, today reported financial results for the three months ended March 31, 2022 .
April 28, 2022
iRhythm Technologies Announces Hiring of Dr. Mintu Turakhia as Chief Medical Officer and Chief Scientific Officer
SAN FRANCISCO , April 28, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today announced that Mintu Turakhia , M.D. M.A.S., will join iRhythm in the new role of Chief Medical Officer and
April 21, 2022
iRhythm Technologies to Report First Quarter 2022 Financial Results on May 5, 2022
SAN FRANCISCO , April 21, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today announced that it will release financial results for the first quarter 2022 after the close of trading on
April 3, 2022
Zio® by iRhythm Shown to Prevent Hospital Admissions, Aid in Early Detection of AF
New clinical research presented at ACC.22 shows that the Zio service is a viable solution for the early detection of silent atrial fibrillation Additional data shows that Zio AT can positively impact hospital resources – saving one healthcare system 136 inpatient hospitalization days SAN FRANCISCO
March 29, 2022
iRhythm Technologies Announces Amendment to Term Loan Agreement
Provides enhanced credit facility up to $100 million with favorable terms and facility maturity extended to March 2027 SAN FRANCISCO , March 29, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac
March 14, 2022
iRhythm® Technologies Announces Kevin King to Retire from Board of Directors
SAN FRANCISCO , March 14, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC) (“iRhythm”), a leading digital healthcare solutions company focused on the advancement of cardiac care, today announced that Kevin King will retire from iRhythm’s Board of Directors effective April 1, 2022
February 28, 2022
Zio® by iRhythm Shows Significantly Higher Documentation of Atrial Fibrillation and Atrial Flutter Compared to Holter Monitors, Event Monitors
Additional clinical research shows bradyarrhythmias can be detected with 14-day cardiac monitoring through Zio XT before and after TAVR SAN FRANCISCO , Feb. 28, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital healthcare solutions company focused on the
February 23, 2022
iRhythm Technologies Announces Fourth Quarter and Full Year 2021 Financial Results
SAN FRANCISCO , Feb. 23, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, today reported financial results for the three months and full year ended December 31, 2021 .
February 9, 2022
iRhythm Technologies to Report Fourth Quarter and Full Year 2021 Financial Results on February 23, 2022
SAN FRANCISCO , Feb. 09, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today announced that it will release financial results for the fourth quarter and full year 2021 after the close
January 10, 2022
iRhythm Technologies Comments on Medicare Administrative Contractor 2022 Rate Update
SAN FRANCISCO , Jan. 10, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, commented on ​​the recent update by Novitas Solutions (Novitas), a Medicare Administrative Contractor (MAC),